Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

7.68

-0.69 (-8.24%)

At close: Aug 28, 2026, 4:00 PM EDT

7.79

+0.11 (1.40%)

After-hours: Aug 28, 2026, 7:46 PM EDT

MRVI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	70.09	216.89	322.4	574.96	632.14	551.27
Trading Asset Securities	-	-	1.38	-	-	-
Cash & Short-Term Investments	70.09	216.89	323.77	574.96	632.14	551.27
Cash Growth	-74.03%	-33.01%	-43.69%	-9.04%	14.67%	133.41%
Accounts Receivable	31.14	25.5	38.52	54.61	138.62	117.51
Other Receivables	-	-	-	1.1	8.19	-
Receivables	31.14	25.5	38.52	55.71	146.81	117.51
Inventory	41.23	40.5	50.08	51.4	43.15	51.56
Prepaid Expenses	12.71	13.37	16.77	17.85	25.8	19.7
Total Current Assets	155.66	296.25	429.15	699.91	847.9	740.04
Property, Plant & Equipment	142.41	190.74	217.03	222.65	116.59	95.43
Long-Term Investments	-	-	-	8.56	11.36	0.54
Goodwill	129.43	129.43	159.88	326.03	283.67	152.77
Other Intangible Assets	138.38	151.54	194.96	220.99	216.66	117.57
Long-Term Deferred Tax Assets	-	-	-	-	765.8	808.12
Long-Term Deferred Charges	0.6	-	-	-	-	-
Other Long-Term Assets	37.27	2.62	7.24	9.32	40.33	3.82
Total Assets	603.75	770.58	1,008	1,487	2,282	1,918

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.13	2.91	11.96	10.73	5.99	8.15
Accrued Expenses	13.21	22.6	28.02	29.04	35.44	28.32
Current Portion of Long-Term Debt	1.13	5.44	5.44	5.44	5.44	6
Current Portion of Leases	9.53	8.76	8.27	7.41	6.27	3.72
Current Income Taxes Payable	-	-	-	-	-	0.1
Current Unearned Revenue	5.4	2.99	3.29	5.52	4.75	12.64
Other Current Liabilities	2.03	2.22	-	29.33	52.25	34.84
Total Current Liabilities	38.42	44.92	56.97	87.47	110.14	93.78
Long-Term Debt	145.98	286.33	290.49	518.71	522	524.59
Long-Term Leases	61.47	64.18	72.49	79.41	51.56	40.91
Long-Term Deferred Tax Liabilities	-	2.25	0.01	-	-	-
Other Long-Term Liabilities	2.29	0.2	11.07	11.98	693.38	713.64
Total Liabilities	248.16	397.87	431.04	697.57	1,377	1,373

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	2.6	2.56	2.53	2.51	2.55	2.55
Additional Paid-In Capital	207.6	199.18	181.87	128.5	137.9	128.39
Retained Earnings	-6.03	10.12	140.89	285.74	404.77	184.56
Comprehensive Income & Other	0.46	0.52	-	-	-	-
Total Common Equity	204.62	212.38	325.29	416.75	545.22	315.5
Minority Interest	150.97	160.33	251.92	373.13	360.03	229.86
Shareholders' Equity	355.59	372.71	577.21	789.88	905.24	545.36
Total Liabilities & Equity	603.75	770.58	1,008	1,487	2,282	1,918

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	218.1	364.71	376.69	610.97	585.26	575.22
Net Cash (Debt)	-148.01	-147.82	-52.92	-36.01	46.88	-23.95
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.01	-1.02	-0.38	-0.27	0.18	-0.09
Filing Date Shares Outstanding	148.99	146.38	143.65	132.31	131.79	131.49
Total Common Shares Outstanding	148.89	145.32	141.98	132.23	131.69	131.49
Working Capital	117.24	251.33	372.18	612.44	737.76	646.26
Book Value Per Share	1.37	1.46	2.29	3.15	4.14	2.40
Tangible Book Value	-63.18	-68.59	-29.54	-130.26	44.89	45.16
Tangible Book Value Per Share	-0.42	-0.47	-0.21	-0.99	0.34	0.34
Machinery	-	82.06	73.36	48.79	35.91	31.07
Construction In Progress	-	14.68	23.76	39.64	13.19	6.92
Leasehold Improvements	-	39.25	37.59	24.87	20.1	18.16

SEC Filings: 10-K · 10-Q